Incretin-based therapies

Intervention4 papers3 findings

Outcomes

2

Fat mass

downin reviews1

1 study

Incretin-based therapies decrease fat mass.
Reviewobesity treatment
Weight Loss or Muscle Loss? Cellular Mechanisms and Clinical Strategies for Preserving Lean Mass During GLP-1-Based Therapy · Diabetes, obesity & metabolism · 7 Oct 2026

Body weight

downin humans1

1 study

Incretin-based therapies decrease body weight in humans.
Review
Real-World Evidence for Existing Anti-Obesity Therapies-The Realities of Treatment Adherence, Tolerability, Access and Patient Satisfaction · Diabetes, obesity & metabolism · 14 Sep 2026

Associations

1

Anemia

upin humans1

1 study

Incretin-based therapies are associated with anemia in humans.
Review
The Possible Hematological Cost of Metabolic Success: Do Incretin-Based Therapies Silently Trigger Anemia? · Medical sciences (Basel, Switzerland) · 17 Sep 2026

Latest

4

Diabetes, Obesity & MetabolismReview2 h

Weight Loss or Muscle Loss? Cellular Mechanisms and Clinical Strategies for Preserving Lean Mass During GLP-1-Based Therapy

Medical SciencesReview24 Sep

The Possible Hematological Cost of Metabolic Success: Do Incretin-Based Therapies Silently Trigger Anemia?

Cardiac Failure ReviewReview23 Sep

Obesity in Heart Failure: Mechanistic, Diagnostic and Therapeutic Considerations

Diabetes, Obesity & MetabolismReview15 Sep

Real-World Evidence for Existing Anti-Obesity Therapies-The Realities of Treatment Adherence, Tolerability, Access and Patient Satisfaction